Patents by Inventor Larry Cameron Anthony

Larry Cameron Anthony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160024534
    Abstract: Yeast strains were engineered that have increased activity of heterologous proteins that require binding of an Fe—S cluster for their activity. The yeast strains have reduced activity of an endogenous Fe—S protein. Activities of heterologous fungal or plant 2Fe-2S dihydroxy-acid dehydratases and Fe—S propanediol dehydratase reactivase were increased for increased production of products made using biosynthetic pathways including these enzymes, such as valine, isoleucine, leucine, pantothenic acid (vitamin B5), isobutanol, 2-butanone and 2-butanol.
    Type: Application
    Filed: October 2, 2015
    Publication date: January 28, 2016
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall, Steven Cary Rothman, Jean-Francois Tomb
  • Publication number: 20150368656
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Application
    Filed: September 9, 2015
    Publication date: December 24, 2015
    Inventor: Larry Cameron Anthony
  • Patent number: 9206447
    Abstract: Yeast strains were engineered that have increased activity of heterologous proteins that require binding of an Fe—S cluster for their activity. The yeast strains have reduced activity of an endogenous Fe—S protein. Activities of heterologous fungal or plant 2Fe-2S dihydroxy-acid dehydratases and Fe—S propanediol dehydratase reactivase were increased for increased production of products made using biosynthetic pathways including these enzymes, such as valine, isoleucine, leucine, pantothenic acid (vitamin B5), isobutanol, 2-butanone and 2-butanol.
    Type: Grant
    Filed: September 29, 2009
    Date of Patent: December 8, 2015
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Steven Cary Rothman, Jean-Francois Tomb
  • Patent number: 9163266
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Grant
    Filed: June 11, 2014
    Date of Patent: October 20, 2015
    Assignee: BUTAMAX ADVANCED BIOFUELS LLC
    Inventor: Larry Cameron Anthony
  • Publication number: 20150240267
    Abstract: Provided herein are processes and microorganisms which utilize both protein hydrolysates and carbohydrates from biomass feedstocks to produce renewable hydrocarbon compositions. Advantages of the disclosed methods may be recognized in fuel blends comprising such hydrocarbon compositions.
    Type: Application
    Filed: September 20, 2013
    Publication date: August 27, 2015
    Inventors: Larry Cameron Anthony, Tyler T. Ames, Keith H. Burlew
  • Publication number: 20150125920
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Application
    Filed: December 16, 2014
    Publication date: May 7, 2015
    Inventors: LARRY CAMERON ANTHONY, LORI ANN MAGGIO-HALL
  • Patent number: 8969065
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: March 3, 2015
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall
  • Patent number: 8956850
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Grant
    Filed: June 4, 2009
    Date of Patent: February 17, 2015
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall
  • Publication number: 20140308735
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Application
    Filed: June 11, 2014
    Publication date: October 16, 2014
    Applicant: BUTAMAX ADVANCED BIOFUELS LLC
    Inventor: Larry Cameron ANTHONY
  • Publication number: 20140273130
    Abstract: Provided herein are recombinant yeast host cells and methods for their use for production of fermentation products. Host cells provided herein comprise a pyruvate-utilizing pathway and a competitive growth advantage over other microorganisms in solution.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron ANTHONY, Michael Dauner
  • Patent number: 8828694
    Abstract: Yeast cells with modified expression of certain enzyme activities in the mitochondria are described for isobutanol production. Modifications described provide an isobutanol biosynthesis pathway in the yeast mitochondria.
    Type: Grant
    Filed: November 12, 2009
    Date of Patent: September 9, 2014
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Lixuan Lisa Huang, Rick W. Ye
  • Patent number: 8785166
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: July 22, 2014
    Assignee: Butamax Advanced Biofuels LLC
    Inventor: Larry Cameron Anthony
  • Publication number: 20140186911
    Abstract: Provided herein are recombinant yeast cells comprising a deletion or disruption in an endogenous gene encoding Amn1 and a heterologous gene encoding Amn1. Also provided are recombinant yeast cells comprising a heterologous gene encoding Amn1 and an engineered butanol biosynthetic pathway. Further provided are methods of producing isobutanol comprising providing the recombinant yeast cells described herein and culturing the recombinant yeast cells under conditions wherein isobutanol is produced.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 3, 2014
    Applicant: BUTAMAX ADVANCED BIOFUELS LLC
    Inventors: Arthur Leo Kruckeberg, Larry Cameron Anthony
  • Publication number: 20140162333
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Application
    Filed: January 22, 2014
    Publication date: June 12, 2014
    Applicant: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron ANTHONY, Lori Ann Maggio-Hall
  • Publication number: 20140141479
    Abstract: The invention relates to a recombinant host cell having (a) a modification in an endogenous polynucleotide encoding a polypeptide having dual-role hexokinase activity; (b) a heterologous polynucleotide encoding a polypeptide having hexose kinase activity; and optionally (c) a modification in an endogenous polynucleotide encoding a polypeptide having pyruvate decarboxylase activity. Additionally, the invention relates to methods of making and using such recombinant host cells including, for example, methods of increasing glucose consumption, methods of improving redox balance, and/or methods of increasing the production of a product of a pyruvate-utilizing pathway.
    Type: Application
    Filed: January 24, 2014
    Publication date: May 22, 2014
    Applicant: BUTAMAX(TM) ADVANCED BIOFUELS LLC
    Inventors: Larry Cameron Anthony, Arthur Leo Kruckeberg, Brian James Paul
  • Patent number: 8669094
    Abstract: A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: March 11, 2014
    Assignee: Butamax™ Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Lori Ann Maggio-Hall
  • Patent number: 8637289
    Abstract: The invention relates to a recombinant host cell having (a) a modification in an endogenous polynucleotide encoding a polypeptide having dual-role hexokinase activity; (b) a heterologous polynucleotide encoding a polypeptide having hexose kinase activity; and optionally (c) a modification in an endogenous polynucleotide encoding a polypeptide having pyruvate decarboxylase activity. Additionally, the invention relates to methods of making and using such recombinant host cells including, for example, methods of increasing glucose consumption, methods of improving redox balance, and/or methods of increasing the production of a product of a pyruvate-utilizing pathway.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: January 28, 2014
    Assignee: Butamax(TM) Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Arthur Leo Kruckeberg
  • Publication number: 20140024094
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Application
    Filed: May 8, 2013
    Publication date: January 23, 2014
    Applicant: Butamax Advanced Biofuels LLC
    Inventor: Larry Cameron ANTHONY
  • Patent number: 8465964
    Abstract: Yeast cells with reduced activity of certain enzymes involved in branched chain amino acid biosynthesis in yeast mitochondria are described. Target enzymes include threonine deaminase, isopropylmalate synthase, and optionally branched chain amino acid transaminase.
    Type: Grant
    Filed: November 12, 2009
    Date of Patent: June 18, 2013
    Assignee: Butamax (TM) Advanced Biofules LLC
    Inventor: Larry Cameron Anthony
  • Publication number: 20130071898
    Abstract: Provided herein are recombinant yeast host cells and methods for their use for production of isobutanol. Yeast host cells provided comprise an isobutanol biosynthetic pathway and at least one of reduced or eliminated aldehyde dehydrogenase activity, reduced or eliminated acetolactate reductase activity; or a heterologous polynucleotide encoding a polypeptide having ketol-acid reductoisomerase activity.
    Type: Application
    Filed: March 23, 2012
    Publication date: March 21, 2013
    Applicant: Butamax(TM) Advanced Biofuels LLC
    Inventors: LARRY CAMERON ANTHONY, Hongxian He, Lixuan Lisa Huang, Daniel P. Okeefe, Arthur Leo Kruckeberg, Yougen Li, Lori Ann Maggio-Hall, Jessica Mcelvain, Mark J. Nelson, Ranjan Patnaik, Steven Cary Rothman